Production (Stage)
Tenax Therapeutics, Inc.
TENX
$6.15
$0.081.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -139.64% | -128.27% | -107.01% | -57.58% | -3.80% |
| Total Depreciation and Amortization | -- | -- | -84.11% | -89.77% | -91.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,824.45% | 431.37% | -15.37% | -19.00% | -24.63% |
| Change in Net Operating Assets | 404.45% | 3.76% | 477.34% | 1,867.89% | 154.54% |
| Cash from Operations | -77.76% | -150.87% | -94.14% | -49.37% | 8.16% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -92.86% | -92.86% | 50.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -97.06% | -97.06% | -65.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 31.31% | 19.68% | -690.87% | -9,365.00% | -2,478.26% |
| Issuance of Common Stock | 133,088.17% | 535.21% | 535.21% | -99.99% | -99.69% |
| Repurchase of Common Stock | -592.47% | -592.47% | -72.89% | -82.62% | -82.62% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 450.86% | 665.60% | 184.32% | 194.07% | 194.07% |
| Cash from Financing | 1,444.83% | 636.02% | 624.80% | -46.17% | -65.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5,399.41% | 1,009.27% | 1,088.43% | -165.06% | -116.16% |